首页> 外文期刊>Breast cancer >Hormone receptor status of contralateral breast cancers: analysis of data from the US SEER population-based registries
【24h】

Hormone receptor status of contralateral breast cancers: analysis of data from the US SEER population-based registries

机译:对侧乳腺癌的激素受体状态:基于美国SEER人群登记系统的数据分析

获取原文
           

摘要

Background Women diagnosed with breast cancer display higher propensity to develop second primary cancer in the contralateral breast (CBC). Identification of patients with increased risk of CBC and understanding relationships between hormone receptor (HR) statuses of the first and second breast cancers is desirable for endocrine-based prevention strategies.MethodsUsing 1992–2012 data from 13 SEER registries, the risk of developing CBC was determined as ratio of observed and expected second breast cancers (SIR). Association between HR statuses was examined by exploratory data analysis and multivariable logistic regression. Results: Women with ER-positive and ER-negative breast cancers have increased risk of developing CBC with SIR values 2.09 (CI 95?=?1.97–2.21) and 2.40 (CI 95?=?2.18–2.63), respectively. ER statuses of the CBC are moderately positively associated. In metachronous CBC, most cases with ER-positive first cancers had ER-positive second breast cancers (81.6?%; CI 95?=?80.2–82.9?%); however, considerable proportion of cases with ER-negative first cancers had ER-positive second cancers (48.8?%; CI 95?=?46.2–51.4?%).ConclusionsSome women with ER-negative breast cancers may benefit from endocrine-based prevention of ER-positive CBC.
机译:背景技术被诊断出患有乳腺癌的女性在对侧乳腺(CBC)中发展出第二原发癌的可能性更高。识别具有增加的CBC风险的患者并了解第一和第二位乳腺癌的激素受体(HR)状态之间的关系对于基于内分泌的预防策略是理想的。方法使用来自13个SEER注册中心的1992-2012年数据,发展CBC的风险为确定为观察到的和预期的第二种乳腺癌(SIR)之比。通过探索性数据分析和多变量logistic回归检查了HR状态之间的关联。结果:ER阳性和ER阴性乳腺癌的女性患CBC的风险增加,SIR值分别为2.09(CI 95?=?1.97–2.21)和2.40(CI 95?=?2.18–2.63)。 CBC的ER状态呈中等正相关。在异时CBC中,大多数ER阳性的第一乳腺癌患者为ER阳性的第二乳腺癌(81.6%; CI 95%=?80.2–82.9%)。但是,相当一部分患有ER阴性的第一癌症的患者患有ER阳性的第二癌症(48.8%; CI 95%=?46.2-51.4%)。结论一些患有ER阴性乳腺癌的女性可能会受益于基于内分泌的预防ER阳性的CBC。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号